New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Neuphoria Therapeutics Inc. (NEUP) vs Tvardi Therapeutics, Inc. (TVRD)
- Neuphoria Therapeutics Inc. NEUP 2.35 +1.29%
- Tvardi Therapeutics, Inc. TVRD 0.99 +4.21%
Neuphoria Therapeutics Inc. and Tvardi Therapeutics, Inc. are both Biotechnology companies. Neuphoria Therapeutics Inc. and Tvardi Therapeutics, Inc. are of similar size ($12.6M and $12.6M). Across the 12 metrics below, Neuphoria Therapeutics Inc. leads on 7 and Tvardi Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | NEUP | TVRD | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 146.85% | 70.18% |
| Operating margin | — | (36.92%) | 0.00% |
| Net margin | — | (459.31%) | 0.00% |
| Free cash flow margin | — | 58.90% | 0.00% |
| Return on equity | (27.63%) | (123.08%) | (51.58%) |
| Return on assets | (18.26%) | (85.24%) | (45.91%) |
| Return on invested capital | (186.04%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack